Skip to content

The Response of Pathogens to the Respective or Combined Treatment of SRP and Local Minocycline in Chronic Periodontitis

The Response of Periodontal Pathogens to the Respective or Combined Treatment of Scaling and Root Planning and Locally Delivered Minocycline in Patients With Chronic Periodontitis- a Short-term Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02355977
Enrollment
70
Registered
2015-02-04
Start date
2013-06-30
Completion date
2014-12-31
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Keywords

Chronic periodontitis, Minocycline, Surface and root planning, Pocket depth, Sulcus bleeding index, Prevotella intermedia

Brief summary

To evaluate the respective or combinatory efficacy of locally delivered 2% Minocycline (MO) and surface and root planning (SRP) by assessing both clinical parameters and the loads of four main periodontal pathogens in treating chronic periodontitis.

Detailed description

In this randomized clinical trial, the investigators will evaluate the respective or combinatory efficacy of minocycline and scaling and root planning in the aspects of both clinical parameters \[Pocket depth (PD) and sulcus bleeding index (SBI)\] and the loads of four main periodontal pathogens \[Aggregatibacter actinomycetemcomitans (Aa), Fusobacterium nucleatum (Fn), Porphyromonas gingivalis (Pg) and Prevotella intermedia (Pi)\]. Real-time quantitative PCR (qRT-PCR) will be used as a powerful tool with high sensitivity and specificity to quantitatively assess target periodontal bacteria in a period of 7 days. The investigators will also try to correlate the reduction of either total or respective bacteria with the improvements of clinical parameters, with an aim to uncovering the potential microbiological mechanism accounting for the efficacy of a therapy.

Interventions

DRUGminocycline

Periocline dental ointment

PROCEDUREsurface and root planning

surface and root planning

Sponsors

Academic Centre for Dentistry in Amsterdam
CollaboratorOTHER
Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diagnosed with moderate or severe chronic periodontal disease, and exhibited bleeding on probing and attachment loss, with radiographic alveolar bone loss in four or more teeth

Exclusion criteria

* pregnant, had used antibiotics within the last 3 months, had periodontal therapy in the past 6 months or had systemic diseases such as heart disease or hypertension

Design outcomes

Primary

MeasureTime frameDescription
Pocket Depth7 daysPD is measured using a standard CPI(community periodontal index) probe (Shanghai Medical Instruments, Shanghai, China) and assessed to the nearest millimeter.

Secondary

MeasureTime frameDescription
Bleeding on Probing7 daysBOP is evaluated for the treated tooth using the sulcus bleeding index (SBI) by Muhlemann with a range of 0 (no bleeding) to 5 (profuse bleeding)
Bacterial Load7 daysReal-time quantitative PCR (qRT-PCR) was used as a powerful tool with high sensitivity and specificity to quantitatively assess target periodontal bacteria.

Participant flow

Participants by arm

ArmCount
Surface and Root Planning
surface and root planning is performed in a single-visit, one-stage, full mouth pattern using periodontal ultrasonic scaler (Satelec, Mérignac, France) surface and root planning: surface and root planning
21
Locally Delivered Minocycline
Locally delivered minocycline is administered directly into the periodontal pocket up to the gingival margin of the selected teeth minocycline: Periocline dental ointment surface and root planning: surface and root planning
26
Surface and Root Planning+Minocycline
surface and root planning+locally delivered minocycline is the combined administration of both surface and root planning and locally delivered minocycline. minocycline: Periocline dental ointment
23
Total70

Baseline characteristics

CharacteristicSurface and Root PlanningLocally Delivered MinocyclineSurface and Root Planning+MinocyclineTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants4 Participants1 Participants6 Participants
Age, Categorical
Between 18 and 65 years
20 Participants22 Participants22 Participants64 Participants
Age, Continuous47 years
STANDARD_DEVIATION 15
50 years
STANDARD_DEVIATION 13
49 years
STANDARD_DEVIATION 11
49 years
STANDARD_DEVIATION 13
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants26 Participants23 Participants70 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
China
21 participants26 participants23 participants70 participants
Sex: Female, Male
Female
13 Participants9 Participants12 Participants34 Participants
Sex: Female, Male
Male
8 Participants17 Participants11 Participants36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 210 / 260 / 23
serious
Total, serious adverse events
0 / 210 / 260 / 23

Outcome results

Primary

Pocket Depth

PD is measured using a standard CPI(community periodontal index) probe (Shanghai Medical Instruments, Shanghai, China) and assessed to the nearest millimeter.

Time frame: 7 days

ArmMeasureValue (MEAN)Dispersion
Surface and Root PlanningPocket Depth4.34 mmStandard Deviation 0.57
Locally Delivered MinocyclinePocket Depth4.81 mmStandard Deviation 0.99
Surface and Root Planning+MinocyclinePocket Depth4.5 mmStandard Deviation 0.53
Secondary

Bacterial Load

Real-time quantitative PCR (qRT-PCR) was used as a powerful tool with high sensitivity and specificity to quantitatively assess target periodontal bacteria.

Time frame: 7 days

Population: The analyzed units of the gene load of bacteria are log10.

ArmMeasureGroupValue (MEAN)Dispersion
Surface and Root PlanningBacterial LoadAggregatibacter actinomycetemcomitans (Aa)5.55 log10 (copies/ml)Standard Deviation 0.59
Surface and Root PlanningBacterial LoadFusobacterium nucleatum (Fn)6.77 log10 (copies/ml)Standard Deviation 0.39
Surface and Root PlanningBacterial LoadPorphyromonas gingivalis (Pg)7.11 log10 (copies/ml)Standard Deviation 1.77
Surface and Root PlanningBacterial LoadPrevotella intermedia (Pi)4.98 log10 (copies/ml)Standard Deviation 0.72
Locally Delivered MinocyclineBacterial LoadPrevotella intermedia (Pi)4.58 log10 (copies/ml)Standard Deviation 1.16
Locally Delivered MinocyclineBacterial LoadAggregatibacter actinomycetemcomitans (Aa)4.32 log10 (copies/ml)Standard Deviation 1.67
Locally Delivered MinocyclineBacterial LoadPorphyromonas gingivalis (Pg)6.72 log10 (copies/ml)Standard Deviation 1.73
Locally Delivered MinocyclineBacterial LoadFusobacterium nucleatum (Fn)6.37 log10 (copies/ml)Standard Deviation 0.43
Surface and Root Planning+MinocyclineBacterial LoadPrevotella intermedia (Pi)4.77 log10 (copies/ml)Standard Deviation 0.92
Surface and Root Planning+MinocyclineBacterial LoadFusobacterium nucleatum (Fn)6.72 log10 (copies/ml)Standard Deviation 0.42
Surface and Root Planning+MinocyclineBacterial LoadPorphyromonas gingivalis (Pg)7.13 log10 (copies/ml)Standard Deviation 1.78
Surface and Root Planning+MinocyclineBacterial LoadAggregatibacter actinomycetemcomitans (Aa)4.77 log10 (copies/ml)Standard Deviation 0.86
Secondary

Bleeding on Probing

BOP is evaluated for the treated tooth using the sulcus bleeding index (SBI) by Muhlemann with a range of 0 (no bleeding) to 5 (profuse bleeding)

Time frame: 7 days

ArmMeasureValue (MEAN)Dispersion
Surface and Root PlanningBleeding on Probing1.42 units on a scaleStandard Deviation 0.55
Locally Delivered MinocyclineBleeding on Probing1.23 units on a scaleStandard Deviation 0.7
Surface and Root Planning+MinocyclineBleeding on Probing1.42 units on a scaleStandard Deviation 0.55

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026